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Aconservedlipid-modiﬁedcysteinefoundinaproteinmotifcommonlyreferredtoasalipoboxmediatesthemembraneanchoring
of a subset of proteins transported across the bacterial cytoplasmic membrane via the Sec pathway. Sequenced haloarchaeal
genomes encode many putative lipoproteins and recent studies have conﬁrmed the importance of the conserved lipobox cysteine
for signal peptide processing of three lipobox-containing proteins in the model archaeon Haloferax volcanii.W eh a v ee x t e n d e d
these in vivo analyses to additional Hfx. volcanii substrates, supporting our previous in silico predictions and conﬁrming the
diversity of predicted Hfx. volcanii lipoproteins. Moreover, using extensive comparative secretome analyses, we identiﬁed genes
encodining putative lipoproteins across a wide range of archaeal species. While our in silico analyses, supported by in vivo data,
indicate that most haloarchaeal lipoproteins are Tat substrates, these analyses also predict that many crenarchaeal species lack
lipoproteins altogether and that other archaea, such as nonhalophilic euryarchaeal species, transport lipoproteins via the Sec
pathway. To facilitate the identiﬁcation of genes that encode potential haloarchaeal Tat-lipoproteins, we have developed TatLipo,
a bioinformatic tool designed to detect lipoboxes in haloarchaeal Tat signal peptides. Our results provide a strong foundation for
future studies aimed at identifying components of the archaeal lipoprotein biogenesis pathway.
1.Introduction
Most precursors of secreted prokaryotic proteins are trans-
ported across cytoplasmic membranes via either the univer-
sally conserved Sec pathway or the Twin-arginine transloca-
tion (Tat) pathway [1, 2]. The targeting of secreted protein
precursors to these translocation pathways is dependent
upon the recognition of pathway-speciﬁc signal peptides
[1, 3]. In bacteria, most substrates transported via these
pathways contain a signal peptide processing site that is
recognized by signal peptidase I (SPase I) after transfer
through the cytoplasmic membrane [3, 4]. However, one
type of secreted protein, the bacterial lipoprotein precur-
sors, is processed by signal peptidase II (SPase II), which
speciﬁcally recognizes a conserved “lipobox” motif at the C-
terminus of the signal peptide [4, 5]. The lipobox contains
a cysteine residue to which a glyceride-fatty acid lipid is
attached by a prolipoprotein diacylglyceryl transferase (Lgt)
[6,7].SPaseIIcleavestheprecursorimmediatelyupstreamof
this lipid-modiﬁed cysteine. In Gram-negative and some
Gram-positive bacteria, the conserved lipobox cysteine
residue is also acylated by apolipoprotein N-acyltransferase
[8, 9].
Sequence analyses of genomes isolated from archaea
that thrive in high salt environments have identiﬁed a
large number of open reading frames that encode putative
Tat substrates containing potential lipoboxes [10–13]. Mass
spectrometry results of the haloalkaliphilic halocyanin from
Natronomonas pharaonis was consistent with the presence of
an N-terminal cysteine residue modiﬁed by a lipid consisting
of two C20 phytanyl groups linked to a glycerol group and
also being acetylated at the amino group [13].2 Archaea
When the conserved lipobox cysteine residue is replaced
with a serine residue, putative Hfx. volcanii lipoprotein
precursors are not processed, suggesting that these haloar-
chaeal Tat substrates are in fact lipoproteins [12]. Interest-
ingly, while unprocessed precursors of similar replacement
mutants remain cell-associated in bacteria, the three mutant
Hfx. volcanii precursors thus far tested are secreted into the
supernatant [12]. Homologs of bacterial lipid-modiﬁcation
enzymes have not been detected in archaeal genomes. Con-
sidering this, release of the unprocessed mutant constructs
into the extracellular environment supports the hypothesis
that the molecular mechanisms underlying archaeal lipopro-
tein biosynthesis are distinct from their bacterial counter-
parts. It should also be noted that recently published data
has revealed that some Gram-positive bacterial lipoproteins
are also Tat substrates [14, 15]; however, little is known
about the lipid-anchoring process in these bacteria. One
possible interpretation of this result was that the release of
the haloarchaeal Tat precursor proteins into the supernatant
might reﬂect a diﬀerence in the mechanisms involved in
lipid-modiﬁcation of Sec and Tat substrates.
Inthisstudy,wecarriedoutadditionalinvivoandinsilico
analyses to gain further insight into the processes involved
in archaeal Tat and Sec lipoprotein biosynthesis and the
diversity of archaeal lipoproteins. Although replacing the
lipobox cysteine of additional putative Tat lipoproteins with
a serine blocked precursor processing, these unprocessed
mutant proteins remained membrane associated, indicating
that secretion of unprocessed cysteine to serine replacement
mutants is not a universal phenomenon, for either archaeal
lipoprotein precursors or for Tat substrate lipoproteins.
Conversely, complementary in silico analyses suggest that
an extensive use of lipid-anchoring by membrane-associated
T a ts u b s t r a t e si sr e s t r i c t e dt oh a l o a r c h a e aw h i l ei ta p p e a r s
to be rare, or even non-existent, in other archaeal phyla.
To identify genes that encode putative lipoprotein precur-
sors, we employed existing lipoprotein prediction programs
primarily trained on sets of bacterial Sec lipoproteins. This
allowed us to compile a set of 484 putative lipoproteins from
six haloarchaeal genomes. These data were used to develop
a novel Tat-speciﬁc lipoprotein prediction tool for halophilic
archaea.
2.MaterialsandMethods
2.1. Reagents. All enzymes used in standard molecular biol-
ogy procedures were purchased from New England Biolabs,
except for iProof High-Fidelity DNA Polymerase, which was
purchased from Biorad. The ECL Plus Western blotting
system, horseradish peroxidase-linked sheep anti-mouse
antibody was purchased from Amersham Biosciences. The
anti-myc monoclonal antibody and polyvinylidene diﬂuo-
ride membrane were purchased from Millipore. DNA and
plasmid puriﬁcation kits, and the anti-Penta-His antibody
were purchased from QIAGEN. NuPAGE gels, buﬀers, and
reagents were purchased from Invitrogen. Difco agar and
Bacto yeast extract were purchased from Becton, Dickinson
and Company. Peptone was purchased from Oxoid. All other
chemicals and reagents were purchased from either Fisher or
Sigma.
2.2.StrainsandGrowthConditions. Theplasmidsandstrains
used in this study are listed in Supplementary Table 1
(available online at doi:10.1155/2010/410975). Hfx. volcanii
strains were routinely grown at 45◦C in 18% MGM [16].
MGM was supplemented with novobiocin (2.0μgml −1)a n d
thymidine (40μgml −1), when necessary. Escherichia coli
strains were grown at 37◦C in NZCYM and supplemented
with ampicillin (100μgml −1).
2.3. Construction of Expression Vectors. The Hvo B0139,
Hvo 1242,H v o1808,H v o1609, and Hvo 1580 genes were
placed under the control of Pfdx [17] and cloned into
pMLH3 [18] with a C-terminal Myc tag generating plasmids
listed in Supplementary Table 1. Pfdx was ampliﬁed from
pGB70 using the FdxFor and FdxRev primers, and the
substrate genes were ampliﬁed using the relevant primers
(see Supplementary Table 2). Substrate genes were then
placed under the control of Pfdx by overlap PCR, using
both the substrate genes and the fdx promoter fragment
PCR products as template. The resulting Pfdx, Pfdx-B0139,
Pfdx-1242, Pfdx-1808, Pfdx-1609,a n dPfdx-1580 fragments
were digested with BamHI and HindIII, and ligated into
pMLH3thathadbeendigestedwithBamHIandHindIIIand
treated with Calf Intestinal Phosphatase. The sequence of the
construct inserts was conﬁrmed by DNA sequencing.
In addition to the listed Myc-tagged wild-type substrate
constructs, several mutant constructs were generated. In
all cases, wild-type substrate constructs were used as DNA
templates for PCRs. The twin-arginine residues of these
gene products were altered to twin lysines via overlap PCR,
using the above constructs as DNA template and primers
that resulted in replacement of the arginine codons with
lysine codons (AAG) (Supplementary Table 2). For the
genesencodingputativelipoproteinsubstrates,likelylipobox
cysteine codons were altered to serine codons via overlap
PCR, using primers that resulted in replacement of the
cysteine codon with a serine codon (TCG) (Supplementary
Table 2). For signal sequence deletion mutants, the potential
signal sequence located prior to the N-terminal cysteine was
deleted via PCR using primers listed in Supplementary Table
2. The ﬁdelity of these mutant constructs was conﬁrmed
by DNA sequencing. Similar methods were used to clone
Hvo 0494 and Hvo 0494C20S, except that these constructs
were cloned into pRV1-ptna plasmid under the control of
the tryptophan-inducible promoter ptna [19]. Genes were
ampliﬁed using the primers listed in Supplementary Table 2
and inserted into pRV1-ptna digested with NdeI and EcoRI.
Wild-type and mutant constructs were extracted from
DH5α(Invitrogen)andpassedthroughDL739[20]toobtain
nonmethylated DNA, which was subsequently transformed
into Hfx. volcanii strain H99 [21] or KD5 [22] using the
standard PEG method [16].
2.4. Expression and Localization of Tat Substrates. Liquid
cultures of relevant strains were grown until mid-logArchaea 3
(OD600 ∼ 0.5). Subsequently, cells were collected by
centrifugation at 4300g for 10min at 4◦C. The supernatants
were recentrifuged at 4300g for 10min to remove cellular
contamination, and secreted proteins were precipitated with
cold TCA (100%v/v) then washed twice with cold acetone
(80%v/v).ThecellpelletswerewashedoncewithMGMthen
pelleted again as described and resuspended in 1× NuPAGE
lithium dodecyl sulfate (LDS) Sample buﬀer.
2.5. Immunoblotting. All protein samples were stored at
−20◦Ci n1 × N u P A G EL D Ss a m p l eb u ﬀer supplemented
with 50mM dithiothreitol (DTT). Samples were run on
Bis-Tris NuPAGE gels under denaturing conditions using
either morpholinepropanesulfonic acid (MOPS) or 2-(N-
morpholino)ethanesulfonic acid (MES) running buﬀer, or
on Tris-Acetate NuPAGE gels using TA running buﬀer. Pro-
teins were transferred to polyvinylidene diﬂuoride (PVDF)
membraneusingtheBio-RadTransblot-SDSemi-DryTrans-
fer Cell at 15V for 30 minutes. Three buﬀers were used in
semidrytransfer:anodeI[300mMTris,10%(v/v)methanol,
pH 10.4], anode II [25mM Tris, 10% (v/v) methanol,
pH 10.4], and cathode [25mM Tris, 40mM glycine, and
10% (v/v) methanol, pH 9.4]. PVDF membranes were
probed with the primary antibodies anti-Penta-His (1:1000)
or anti-Myc (1:1000) and secondary anti-mouse antibody
(1:10,000). All Western blots shown are representative of at
least two independent experiments.
2.6. Archaeal Secretome Analyses. Various commonly avail-
able bioinformatic tools were used to analyze the secreted
proteins of six haloarchaeal species, nine non-halophilic
euryarchaeal species, nine crenarchaeal species, as well as
three other archaeal species (see Supplementary Table 3).
For lipoprotein predictions, we used three independent
prediction programs: (i) the Prosite position-speciﬁc matrix
PS51257 (PROKAR LIPOPROTEIN) [23]; (ii) LipoP [24];
and (iii) predLipo [25]. To keep false positive predictions
minimal, candidate proteins are considered lipobox-positive
only when they are recognized by at least two of these predic-
tors (also see Supplementary Text and Supplementary Figure
1).ToidentifyTatsubstrates,weusedTatFind[26].Predicted
Tat substrates that were not predicted to be lipoproteins were
designatedTatsubstrateswithanSPaseIcleavagesiteintheir
signal peptides. All predicted lipoproteins not identiﬁed by
TatFind were designated Sec substrates with signal peptides
processed by SPase II.
Phobius [27] was used to identify Sec substrate signal
peptides cleaved by SPase I. However, we used caution
when considering this data, as there is a strong tendency
for Phobius to predict false positives for both Sec signal
peptides and SPase I cleavage sites. Since both the Sec and
Tatpathway-speciﬁcsignalpeptidescontainachargedregion
followed by a hydrophobic core, and many contain an SPase
I cleavage site, Phobius is inclined to misclassify many Tat
signal peptides as Sec signal peptides [28]. Consequently,
we disregarded Phobius predictions of Sec signal peptides
in TatFind positives. Similarly, since SPase I has a relaxed
speciﬁcity, which therefore necessitates relaxed cleavage site
prediction constraints, many lipoproteins cleaved by SPase
II are predicted to have signal peptides processed by SPase
I by Phobius. Consequently, we disregarded Phobius pre-
dictions of SPase I cleavage sites for predicted lipoproteins,
as predicted by the method described above (also see
Supplementary Figure 1).
2.7. Tat Lipoprotein Prediction. To extract position-speciﬁc
amino acid statistics, amino acid sequences of 484
lipoproteins predicted from six haloarchaeal genomes were
“aligned” as follows: for 400 lipoproteins predicted to be Tat
substrates, the sequences of the lipobox and the Tat motif,
as predicted by the lipoprotein prediction programs and
TatFind, respectively, were aligned. These alignments were
attained by introducing a gap of variable length between the
ﬁfth and sixth amino acid residue after the second arginine
of the twin arginine motif.
The lipoprotein set contains 50 TatFind negative
sequences that contain two consecutive arginines in the
chargedregionofthesignalpeptide.However,speciﬁcamino
acid residues at positions +1, +4, +5, and/or +6, relative to
these arginines are not allowed by TatFind. Some of these
sequencesmaybefalsenegativescausedbythestringentrules
applied by TatFind. Therefore, the twin arginines in these
potential false negatives were aligned with the twin arginines
in the Tat motifs of the TatFind positives.
Most of the 34 remaining sequences that were examined
were found to contain a single arginine. We aligned this
arginine with the second arginine of the twin arginines of the
Tat motifs identiﬁed by TatFind unless the preceding residue
was the initiator methionine, in which case we aligned
this arginine with the ﬁrst arginine of the Tat motifs (see
Supplementary Table 4).
The 484 aligned haloarchaeal lipoproteins (Supple-
mentary Table 4) were used to compute position-speciﬁc
amino acid frequencies. These frequencies were used to
develop an algorithm using a rule-based approach to detect
haloarchaeal lipobox motifs. For the positions with the
strongest composition bias, amino acids were categorized as
“required”, “frequent”, “normal”, “tolerated”, or “excluded”.
Required and excluded amino acids were used in regular
expressions, that is, no exceptions were allowed. Tolerated
amino acids are not excluded, although they have not been
found in the set of 484 aligned haloarchaeal lipoproteins
at the corresponding position. However, they are similar to
other amino acids, which have been found (e.g., tyrosine
or tryptophane in positions where phenylalanine is found)
(see also Supplementary Table 5). Moreover, tolerated amino
acid residues are allowed only when other positions are
occupied by frequent amino acids. The rule-based algorithm
is the basis of TatLipo (available at SignalFind.org), which
is an extension of TatFind, a program which identiﬁes
haloarchaeal Tat substrates with a high degree of accuracy
[26, 29].
3. Results
3.1. Some Unprocessed Hfx. volcanii Lipobox Replacement
Mutant Proteins Remain Cell-Associated. To further investi-
gate the diversity of haloarchaeal lipoproteins secreted via4 Archaea
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Figure 1: Tat and Sec signal peptides containing lipobox motifs. N-terminal regions of the precursors of (a) Tat; and (b) Sec substrates with
lipoboxes (bold) predicted by at least two of the three lipoprotein prediction programs (PredLipo, LipoP and Prosite PS51257), with the
exception of Hvo 1242, which was only LipoP-positive. Tat motifs (red) were predicted by TatFind, hydrophobic stretches (underlined), and
SPase I cleavage sites (italics) were predicted by Phobius. An arrow indicates the predicted SPase II cleavage sites.
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Figure 2: Hfx. volcanii proteins Hvo B0139 and Hvo 1242 are Tat substrates that require the lipobox cysteine for processing but not for
anchoring to the cytoplasmic membrane. Western blot analyses of the wild-type (RR), twin lysine replacement mutants (KK), and cysteine
to serine replacement mutants (C21S and C26S for Hvo B0139, and Hvo 1242, resp.). All proteins expressed had C-terminal Myc-tags and
were detected using anti-Myc antibodies. Comparable amounts of protein were loaded in each lane. The migration of molecular weight
standards is indicated on the right. Predicted positions of precursor (p) and mature (m) proteins are indicated.
the Tat pathway, we chose to characterize two additional
proteins with distinct lipobox motifs, Hvo B0139 (VAGC),
predicted by three lipoprotein prediction programs (Prosite,
predLipo and LipoP) and Hvo 1242 (LSGC), which was only
predicted by LipoP (Figure 1(a) and see below). Consistent
with these putative Tat substrates being lipoproteins, we
determined that both are cell-associated (Figures 2(a) and
2(b)).ProteinextractsisolatedfromHfx.volcaniithatexpress
C-terminally Myc-tagged versions of these proteins were
subjected to denaturing polyacrylamide gel electrophoresis
(PAGE), followed by Western blot analyses. When genes
are overexpressed from a plasmid, incomplete processing
of the encoded protein is frequently observed. Consistent
with the presence of a precursor and a processed protein,
anti-Myc antibody detected two distinct protein bands in
Western blots of extracts containing the Myc-tagged version
of Hvo B0139. Only a single protein band was detected
in extracts containing Myc-tagged Hvo 1242. To provide
evidence that these proteins are Tat substrates, we mutated
the essential twin arginines that have been shown to be
essential for protein export by the Tat translocase. Mutant
proteins in which twin arginine residues in the signal
peptide were replaced with twin lysines (Hvo B0139KK
and Hvo 1242KK, resp.) were overexpressed in wild-type
Hfx. volcanii, and protein extracts containing these mutant
proteins were subjected to denaturing PAGE, followed by
Western blot analyses. Hvo B0139KK migrated as a single
protein band, at a position on the gel similar to that of
the Hvo B0139 precursor protein (Figure 2(a)). Moreover,
Western blots of protein fractions isolated from Hfx. volcanii
that overexpress Hvo 1242KK detected one protein band,
which migrates at a slower rate than Hvo 1242, indicating
that this mutant protein is not processed (Figure 2(b)).
Todeterminetheimportanceofputativearchaealprotein
lipoboxes in signal peptide processing and membrane-
anchoring, we replaced the conserved lipobox cysteines inArchaea 5
these archaeal Tat substrates with serines. Western blot
analysis of puriﬁed protein extracts subjected to denaturing
PAGE showed that Hvo B0139C21S and Hvo 1242C26S
replacement mutants migrate at a position on the gel
similar to that of the corresponding precursor, indicating
that the cysteine is required for signal peptidase processing
(Figures 2(a) and 2(b)). Interestingly, although Gim´ enez
et al. showed that DsbA, Mbp, and Ibp cysteine to serine
replacement mutants are released into the supernatant [12],
the precursor forms of Hvo B0139C21S and Hvo 1242C26S
remain cell associated, which might be due to the unpro-
cessed signal serving as a membrane anchor (Figure 2).
3.2. The Transport of Lipobox-Containing Proteins Is Not
Dependent on a Particular Hfx. volcanii TatA Paralog.
Although TatAt is essential for Hfx. volcanii survival under
standard laboratory conditions, TatAo, the Hfx. volcanii
paralog of TatAt, is not [22]. To determine whether the
membrane association of unprocessed cysteine to serine
replacement mutants transported via the Tat pathway
depends upon a TatA paralog distinct from that involved
in transporting similar mutants that are released into the
extracellular environment, we investigated the transport of
the Hvo B0139 and Hvo 1242, as well as DsbA, in Hfx.
volcanii tatAo mutants. We determined that these lipobox-
containing proteins are transported with similar eﬃciencies
in wild-type cells and tatAo mutants (Figures 3(a)–3(c)).
Since the soluble Tat substrate arabinanase is also secreted in
a TatAo-independent manner (Figure 3(d)), it is clear that in
Hfx. volcanii the TatAt role in transport is not limited to the
secretion of lipoproteins.
3.3. Putative Hfx. volcanii Sec Substrate Lipobox C-S Replace-
ment Mutants Are Processed, but Are Relatively Unstable.
To determine whether archaeal Sec substrates containing
lipobox motifs require the conserved cysteine for processing,
we characterized three putative Hfx. vocanii Sec substrates
with potential lipoboxes: Hvo 1808 (LAGC), Hvo 1580
(LSGC), and Hvo 0494 (LAGC). Consistent with Hvo 1808
andHvo 1580beinglipoproteins,theyareprimarilyretained
in cell-associated protein fractions (Figures 4(a) and 4(b)).
Although the supernatant fraction of Hvo 1808 expressing
cultures contained a minor protein band that migrated
with one of the bands seen in the membrane-associated
fraction, it is likely that this results from protein shedding
during the isolation of protein fractions, as is the case
for many bacterial lipoproteins (also observed for the Hfx.
volcanii DsbA, [12]). Shedding may also be the reason why
al a r g ep o r t i o no fH v o0494 is found in the supernatant
fraction (Figure 4(c)). To conﬁrm that these Sec substrates
are processed, we attempted to overexpress signal peptide
deletion mutants of these three proteins (Hvo 1808Δss,
Hvo 1580Δss, and Hvo 0494Δss), which should have the
same molecular weights as the processed proteins. Although
Hvo 1508Δss and Hvo 0494Δss appear to be unstable, as
no corresponding protein was identiﬁed by Western blot
analysis (data not shown), Hvo 1808Δss migrated at the
same position on the gel as the wild-type protein when
separated by denaturing PAGE, indicating that the wild-type
protein is processed (Figure 4(a)).
Interestingly, when the conserved lipobox cysteine in
these Sec substrates was replaced with a serine, Western
blot analysis showed that, when separated by denaturing
PAGE, Hvo 1808C19S and Hvo 1580C24S migrate at the
same position on the gel as the wild-type proteins and are
found in the same relative amounts in the cell-associated
andsupernatantproteinfractions,indicatingthatneitherthe
processing nor the membrane anchoring of these mutant
proteins is dependent on the lipobox cysteine (Figures 4(a)
and 4(b)). In fact, all three Sec substrates also contain
potential SPase I processing sites, as predicted by Phobius
[27] (Figure 1(b)). However, Western blot analyses also
revealed that all three mutant proteins are less abundant
than the corresponding wild-type proteins, in both the cell
associated and the supernatant protein fractions, suggesting
that these replacement mutants are less stable than the wild-
type proteins. In fact, in addition to the mutant proteins
being less abundant than the wild-type proteins, Western
blot analysis of protein fractions containing Hvo 0494C20S
revealed a faster migrating band in the supernatant fraction,
possibly a degradation product (Figure 4(c)).
3.4. Prediction of Archaeal Lipoproteins. Upon determining
that many predicted Hfx. volcanii Tat signal peptides con-
tain putative lipoboxes, and conﬁrming that the conserved
lipobox cysteine in these substrates is important for pre-
cursor processing, we resolved to determine (i) whether Tat
substrates of other haloarchaea frequently contain SPase II
processed signal peptides—as has been suggested for at least
two additional haloarchaea species [10, 11]; (ii) whether
non-halophilic archaeal genomes also encode predicted
lipoproteins; and (iii) whether these putative non-halophilic
lipoproteins are typically predicted Sec or Tat substrates.
As there was no archaeal-speciﬁc lipoprotein
prediction program available, we used other existing
tools: (i) the Prosite position-speciﬁc matrix PS51257
(PROKAR LIPOPROTEIN) [23]a n dL i p o P[ 24], which
have both been mainly trained on lipoproteins encoded
by Gram-negative bacterial genomes; and (ii) predLipo
[25], which has been trained on lipoproteins encoded by
Gram-positive bacterial genomes. The results of these three
predictors did not correlate well for archaeal genomes
(see the Supplementary Text). Only 43% of the initial
predictions were common to all three programs, while 24%
were speciﬁc to only one of them. To increase the reliability
of the prediction, we requested that at least two of the
three prediction programs must be positive for a protein to
consider it a lipoprotein (i.e., as having an SPase II cleavage
site). Excluding results obtained with only a single predictor
resulted in a set of 484 predicted lipoproteins from six
halophilic archaea (Supplementary Table 4). Of these, 56%
were positive by all three predictors and 44% were positive
by only two of the three predictors. In the following, we refer
to these as lipoproteins although experimental conﬁrmation
in archaea is still lacking except for halocyanin from N.
pharaonis [13]. However, we consider the requirement for6 Archaea
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Figure 3: Putative Tat substrate lipoproteins Hvo B0139, Hvo 1242, DsbA and arabinanase are translocated independent of TatAo in Hfx.
volcanii. Western blot analyses of wild-type (RR) Hvo B0139, Hvo 1242, and DsbA (Hvo 1245) and arabinanase (Hvo B0232) expressed in
Hfx. volcanii wild-type (WT) or TatAo deletion mutants (tatAo). All proteins expressed had C-terminal Myc-tags, and were detected using
anti-Myc antibodies. Comparable amounts of protein were loaded in each lane. The migration of molecular weight standards is indicated
on the right. Predicted positions of precursor (p) and mature (m) proteins are indicated. For comparisons of the unprocessed and processed
substrate migration see Figure 2.
positive results from two independent predictors a strong
constraint so that we expect only a small fraction will be
false positives.
The lipoproteins predicted by this method were used in
two ways. Predictions for a total of 27 archaeal genomes
were used for statistical analyses. The set of 484 haloar-
chaeal lipoproteins was used to determine position-speciﬁc
amino acid frequencies, results of which were used to
develop TatLipo, a haloarchaea-speciﬁc prediction program
for lipoproteins that are secreted by the Tat pathway.
3.5. Extensive Anchoring of Tat Substrates via Lipid Anchor
Appears to Be Unique to Haloarchaea. Consistent with previ-
ousanalyses,wedeterminedthat39–55%ofthehaloarchaeal
proteins are secreted via the Tat pathway (Figure 5(a)).
However, although most archaea appear to secrete some of
their proteins via the Tat pathway, Tat substrates account for
no more than 8% of any non-halophilic archaeal secretome
thus far analyzed (Figure 5(a), Supplementary Table 3) [29].
The lack of predicted Tat substrates in the euryarchaea M.
hungatei, M. jannaschii, and M. kandleri,o ri nN. equitans
andN.maritimus,isconsistentwiththeabsenceofhomologs
of Tat pathway components in these organisms ([29]a n d
data not shown).
Conversely, while proteins that contain signal peptides
with lipobox motifs are common in some euryarchaea, we
found that they are absent in many crenarchaea (Figure 5(b),
Supplementary Table 3). In the euryarchaea, the fraction of
predicted lipoproteins is somewhat higher among haloar-
chaea (26–36%) than it is among non-halophilic species (7–
20%). Six of the nine analyzed crenarchaeota completely
lack predicted lipoproteins. Ignicoccus hospitalis, the only
archaeon known to have an outer membrane [30]), is an
unusual crenarchaeon, having a secretome in which 4.2%
of the proteins have a lipobox-containing signal peptide
(Figure 5(b), Supplementary Table 3).
Although roughly half of the haloarchaeal Tat substrates
contain a lipobox motif (46–65%) (Figure 5(c),S u p p l e -
mentary Table 3), we determined that only about 10%
of haloarchaeal Sec substrates contain one (Figure 5(d),
Supplementary Table 3). However, while haloarchaea are
unique among archaea with respect to the portion of
secreted proteins containing the Tat/lipobox combination,
they are relatively similar to other euryarchaea in regard to
the frequency of secreted proteins having the Sec/lipobox
combination (Figure 5(d)).
Furthermore, a large majority (78–87%) of putative
haloarchaeal lipoproteins are secreted via the Tat pathway
(Figure 5(e), Supplementary Table 3). In contrast, this
combination is extremely rare in other archaeal species. In
our in silico analysis, only a single exception was identiﬁed,
protein AF2235 of Archaeoglobus fulgidus has a Tat/lipobox
motif (Figure 5(e), Supplementary Table 3).
The diﬀerence in usage of the Tat pathway and lipid-
anchoring cannot be attributed to a general disparity in the
level of protein secretion in these organisms. While the frac-
tion of secreted proteins varies considerably among archaeal
species, ranging from 3.6% in S. acidocaldarius to 10.7% in
M. hungatei,n om a j o rd i ﬀerences in the range of the portion
of proteins secreted are evident between the various phyla of
archaea (Figure 5(f), Supplementary Table 3).
3.6. Development of TatLipo for Prediction of Haloarchaeal
Tat Lipoproteins. Although a large number of potentialArchaea 7
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Figure 4: Cysteine to serine mutants of Hvo 1808, Hvo 1580,
and Hvo 0494 are less stable than wild-type constructs but appear
to be processed. Western blot analyses of wild-type proteins
(WT), cysteine to serine replacement mutants (Hvo 1808C19S,
Hvo 1580C24S and Hvo 0494C20S), and signal sequence deletion
mutants (ss) of Hvo 1808. All proteins expressed had C-terminal
Myc-tags except for Hvo 0494 and Hvo 0494C20S, which were C-
terminally His-tagged. Myc and His-tagged proteins were detected
using anti-Myc and anti-His antibodies, respectively. Comparable
amounts of protein were loaded in each lane. The migration of
molecular weight standards is indicated on the right. Predicted
positions of precursor (p) and mature (m) proteins are indicated.
Tat substrate lipoproteins were detected using the available
prediction programs, our in vivo results show that our
requirement, that at least two of the three programs used
make a positive prediction, may be overly stringent (Figures
1(a) and 2(b)). This may be because these programs were
trained to search for lipobox motifs within the context
of Sec signal peptides, and although Tat and Sec signal
peptides have signiﬁcant similarities, Tat signal peptides,
in addition to containing a unique twin arginine motif,
are generally longer and contain a less hydrophobic h-
domain than Sec signal peptides. Therefore, to identify
additional potential haloarchaeal lipoproteins, we modiﬁed
TatFind,whichdetectshaloarchaealTatsubstrates,toinclude
haloarchaeal lipobox predictions. Since the vast majority of
haloarchaeal lipoproteins are secreted via the Tat pathway,
this program should identify Tat lipoproteins missed by the
other prediction programs used in this study.
Although there are no conﬁrmed Tat lipoproteins to
use as a training set, the stringent lipoprotein prediction
as described above, provided 484 lipoprotein candidates to
be used in deﬁning a consensus haloarchaeal lipobox motif
(Figure 6). Manual alignments of the N-termini of these
proteins, as described in Materials and Methods, were used
to compute position-speciﬁc amino acid composition and
determined that the most frequent haloarchaeal lipobox
motif is LAGC and that sequence conservation increases
along the motif (leucine: 60.5%, alanine: 83.5%, glycine:
98.8%, cysteine: 100%) (Figure 6 and Supplementary Table
5). Furthermore, we identiﬁed a bias in the amino acid
residue composition both upstream and downstream of the
LAGC sequence. A number of charged or hydrophilic amino
acids (D, E, R, H, K, N, Q) are strictly forbidden in front of
the lipobox motif, and at the position immediately following
the conserved cysteine, leucine and serine are frequent while
aspartic acid and cysteine are excluded.
Moreover, we determined the distance between the twin
arginine and the lipobox motif. The calculated number of
amino acid residues between the second arginine and the
conserved cysteine in the lipobox motif was in the range of
12–21.
To speciﬁcally predict Tat substrates with class II sig-
nal peptides, we incorporated the lipobox algorithm into
TatFind, generating the lipoprotein prediction program
TatLipo. Thus, TatLipo deﬁnes the prevalent haloarchaeal
lipobox motif in Tat substrates (Figure 6). TatLipo was
applied to the set of 400 predicted haloarchaeal lipoproteins
that are secreted via the Tat pathway. Only three proteins
in this set were not predicted by TatLipo: two of these
slightly exceed the distance constraint. TatLipo predicts 113
additional lipoprotein candidates. More than two-thirds of
the additional TatLipo assignments (78 of 113, 69.0%) were
also predicted by one of the three other lipobox prediction
programs, including Hvo 1242, which was LipoP-positive.
Thismayindicatethatmanyoftheadditionalpredictionsare
correctly called as lipoproteins. These partial conﬁrmations
are relatively evenly distributed among the three prediction
programs (41 predLipo, 19 Prosite, 18 LipoP). Within the
subset of lipoprotein candidates secreted via the Tat pathway,
TatLipo conﬁrmed most of the lipobox-containing proteins
that were predicted by only one of the three bacterial
lipoprotein prediction programs.
In conclusion, TatLipo is able to identify nearly all of the
Tat-secreted lipobox proteins in halophilic archaea. While
the stringent rules applied for lipobox assignment may
have resulted in a number of false negatives, experimental
conﬁrmation in the future, will allow us to further improve
the lipobox prediction algorithms.
4. Discussion
Haloarchaea transport a large fraction of their secreted
proteins via the Tat pathway, possibly as an adaptation to the
high salt environments they inhabit. Computational analyses
of putative Tat substrates identiﬁed in several halophilic
archaea have revealed that many of these precursor proteins
also contain potential lipoboxes [10, 11, 22]. These ﬁndings
aresupportedbytheresultsobtainedinthestudiespresented
here, which also show that this predominance of SPase
II cleavage sites in Tat substrates, like the extensive use8 Archaea
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Figure 5: Only haloarchaeal Tat substrates are predicted to be predominantly lipoproteins. The predicted relative proportions are shown
for several types of secreted proteins for halophilic and non-halophilic euryarchaeal species as well as crenarchaeal species and three
species belonging to other archaeal phyla. (a) The percentage of secreted proteins that are Tat substrates. (b) The percentage of secreted
proteins that are lipoproteins. (c) The percentage of Tat substrates that are lipoproteins. (d) The percentage of Sec substrates that are
lipoproteins. (e) The percentage of lipoproteins that are secreted via the Tat pathway. (f) The percentage of proteins that are secreted
(predicted Tat and Sec substrates with SPase I or SPase II cleavae sites). Raw data are available in Supplementary Table 4. Organisms
are abbreviated as follows: haloarchaea (Hamar: Haloarcula marismortui; Hasal: Halobacterium salinarum; Hfvol: Haloferax volcanii;
Hqwal: Haloquadratum walsbyi; Namag: Natrialba magadii; Napha: Natronomonas pharaonis), other euryarchaea (Arcfu: Archaeoglobus
fulgidus;M m a z e :Methanosarcina mazei;P y r f u :Pyrococcus furiosus; Thkod: Thermococcus kodakarensis;M e t h u :Methanospirillum hungatei;
Metja: Methanocaldococcus jannaschii;M e t k a :Methanopyrus kandleri; Picto: Picrophilus torridus; Theac: Thermoplasma acidophilum),
crenarchaea (Apern: Aeropyrum pernix;C a l m a :Caldivirga maquilingensis;H y p b u :Hyperthermus butylicus; Sulac: Sulfolobus acidocaldarius;
Sulso: Sulfolobus solfataricus; Thneu: Thermoproteus neutrophilus;M e t s e :Metallosphaera sedula;P y r a r :Pyrobaculum arsenaticum;I g h o s :
Ignicoccus hospitalis), and other archaea (Nequi: Nanoarchaeum equitans;K o c r y :Korarchaeum cryptoﬁlum; Nitma: Nitrosopumilus
maritimus).Archaea 9
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Figure 6: Conserved lipobox motifs of haloarchaea. Consensus motif was generated using the lipobox motifs of 400 predicted haloarchaeal
Tat lipoproteins (see Supplementary Table 4). The alignment depicts the cleavage site G/A at position −1. Logos were generated using
weblogo (http://weblogo.berkeley.edu/).
of the Tat pathway to translocate secreted proteins, is a
feature that is likely unique to haloarchaea. Moreover, in
addition to revealing that a large portion of haloarchaeal Tat
substrates appear to be lipoprotein precursors, our in silico
analyses have also demonstrated that relatively few archaeal
Sec substrates contain a genuine lipobox.
I nap r e v i o u ss t u d y ,w ed e t e r m i n e dt h a ts o m eh a l o a r -
chaeal Tat substrates contain functional lipoboxes, with core
amino acid sequences LAGC or TAGC, required for proper
processing of the precursor protein and for membrane-
association of the processed protein. While our in silico
and in vivo data indicate that the lipobox cysteine is
strictly conserved, we have determined that in addition to
lipobox glycine, which is found at position −1 in 98% of
the putative lipoboxes that we have identiﬁed, alanine is
occasionally found at position −1. We have now shown
that a haloarchaeal Tat substrate containing an alanine at
lipoboxposition −1requirestheputativelipoboxcysteinefor
proper processing. Moreover, a valine at the ﬁrst position or
a serine at the second position of the lipobox, as observed
in the lipoboxes VAGC and LSAC, respectively, can also
be present in haloarchaeal lipoboxes. Similar to previously
tested replacement mutants, constructs lacking the lipobox
cysteine were not processed. However, while previously
tested mutant substrates were released into the supernatant
[12], in this study, precursors containing lipoboxes in
which the cysteine was replaced with a serine remained cell
associated. The cell association of these mutant proteins
is not that surprising since this is similar to what has
been observed for the majority of bacterial lipoproteins
containing a cysteine to serine lipobox substitution where
unprocessed bacterial Sec substrate lipoprotein replacement
mutants remain tethered to the cytoplasmic membrane via
the hydrophobic stretch of the signal peptide. Analogously, it
ispossiblethattheunprocessedsignalpeptidesofthemutant
Tatsubstratelipoproteinprecursorsinvestigatedinthisstudy
serveasimilarpurpose:anchoringtheseunprocessedmutant
proteins to the archaeal cytoplasmic membrane. It is not
clear why some unprocessed lipoproteins are released into
the supernatant.
We have also determined that membrane-association
of an unprocessed Tat substrate containing a lipobox is
not dependent on a speciﬁc Tat pore component; in fact,
we have only identiﬁed a single archaeal Tat substrate
that speciﬁcally requires TatAo for successful translocation
(data not shown). Moreover, we have also shown that
the soluble secreted protein arabinanase is secreted via Tat
pores containing TatAt, demonstrating that no Tat pore
is speciﬁcally dedicated to the secretion of haloarchaeal
lipoproteins (Figure 3(d)).
Although our analyses clearly indicate that predicted
haloarchaeal lipoprotein precursors are generally trans-
ported to the cytoplasmic membrane via the Tat pathway,
the speciﬁc mechanisms involved in lipid modiﬁcation
and signal peptide cleavage of these substrates are cur-
rently unknown. Lnt is the evolutionarily conserved N-
acyltransferase that catalyzes the acylation of the lipobox
cysteine in Gram-negative bacteria. The acylation of the
conserved lipobox cysteine of lipoproteins has also been
conﬁrmed in the Gram-positive bacteria Bacillus subtilis
and Staphylococcus aureus, but Lnt homologs have not been
identiﬁed in either of these species, indicating that an
unrelated enzyme acylates lipoproteins in these organisms
[31, 32]. Given that archaea also lack Lnt homologs, archaeal
species that produce lipoproteins might also express a
novel, archaeal-speciﬁc N-acyltransferase, or perhaps the
lipoprotein acylation in archaea and Gram-positive bacteria
is performed by an enzyme that is conserved between them.
Ontheotherhand,althoughbothGram-negativeandGram-
positive bacterial species express a conserved prolipopro-
tein diacylglyceryl transferase, an archaeal homolog of this
enzyme has not been identiﬁed, indicating that archaea are
likelytoexpressauniqueenzymethatperformsananalogous
function.
In addition to putative haloarchaeal Tat substrate
lipoproteins, previously reported preliminary evidence has
indicated that some Gram-positive bacterial lipoproteins
may also be Tat substrates [14, 15]. Elucidating the mech-
anisms involved in modifying and processing Tat substrate
lipoproteins in bacteria and archaea will almost certainly
reveal important similarities and key diﬀerences in the
processing of Sec substrate and Tat substrate lipoproteins.
In this study, we determined that cysteine to serine
replacement mutants corresponding to two Sec substrates
containing a putative lipobox are processed, and also showed
that these processed mutants remain membrane-associated,10 Archaea
perhaps by forming protein complexes with other
membrane-bound proteins. The fact that the putative
lipobox in these Sec substrates is conserved in homologous
proteins encoded by other haloarchaeal species is interesting
(data not shown). Although it is not clear whether these
conserved sequences are lipoboxes, their conserved nature
suggests that they may serve an important function. On
the other hand, in bacteria, some lipobox cysteine to serine
replacement mutants are processed by a bacterial SPase I
[33]. Interestingly, all three Sec substrates investigated here
contain predicted SPase I cleavage sites, as determined by
Phobius (Figure 1(b)). Consistent with the hypothesis that
SPase I may have processed these mutant Sec substrates, the
cysteine to serine replacement mutant of the Tat substrate
DsbA also contains a predicted SPase I processing site that
appears to be processed, albeit ineﬃciently [12]. Moreover,
Western blot analyses indicate that the cysteine to serine
replacement mutants are less stable than the corresponding
wild-type proteins, and in the case of Hvo 0494, a smaller
product was detected in the protein fraction isolated from
the supernatant.
Our in silico data suggests that haloarchaea are unique
in anchoring Tat substrates to the membrane via a lipid
anchor. However, in addition, while the vast majority of
the lipobox-containing proteins are secreted via the Tat
pathway, haloarchaea as well as non-halophilic euryarchaeal
genomes contain open reading frames that code for puta-
tive lipoproteins, which are secreted via the Sec pathway.
Therefore, with regard to determining the relative impor-
tance of lipoproteins in the various archaeal phyla, further
investigations of putative archaeal Sec substrate lipoproteins
are necessary. These include investigation of Hfx. volcanii
Sec substrates that contain lipoboxes, such as N-terminal
amino acid sequencing of wild-type substrates and their
corresponding cysteine to serine replacement mutants to
determine their processing sites as well as mass spectrometry
of these substrates to determine whether they are lipid
modiﬁed. Furthermore, in vivo analyses of putative Sec
substrate lipoproteins in non-haloarchaeal species, such as
those predicted to be encoded by the genome of M. mazei,a
geneticallyamenablemethanogen,maybeusefulinshedding
light on the signiﬁcance of putative lipobox motifs in
archaeal Sec substrates.
TatLipo, the ﬁrst lipoprotein prediction program pri-
marily trained on the sequences of haloarchaeal Tat lipobox
motifs, predicts a vast array of haloarchaeal Tat substrates
missed by prediction programs trained solely on bacterial
Sec substrates. In fact, our in silico analyses predicted an
additional 113 haloarchaeal Tat substrate lipoproteins when
resultsgeneratedbyTatLipowereincludedwiththoseofpro-
grams trained on bacterial Sec substrates, making the utility
oflipoproteinpredictionprogramsthatpredictarchaeal-and
Tat-speciﬁclipoproteinsabundantlyclear.Moreover,TatLipo
detected nearly all of the proteins identiﬁed by integrating
the results of three bacteria-based predictors. In addition,
for the subset of Tat-secreted proteins, TatLipo conﬁrmed
two-thirds of the predictions supported by only one of these
three programs, including Hvo 1242, a prediction that was
supported by in vivo mutagenesis data.
The inability of prediction programs trained on Sec sub-
strates to recognize a signiﬁcant portion of the Tat substrate
l i p o p r o t e i n sm a yb ed u et ok e ys t r u c t u r a ld i ﬀerences that
exist between Tat and Sec signal peptides. In particular, Tat
signal peptide hydrophobic stretches are less hydrophobic
and their highly charged regions are longer than the cor-
responding regions of Sec signal peptides [28]. Future in
vivo analyses of predicted archaeal Sec lipoproteins may help
clarify the diversity of archaeal lipoproteins and may also
allow the development of an archaeal Sec lipoprotein predic-
tion program, analogous to TatLipo. Moreover, considering
the fact that Gram-negative and Gram-positive bacterial Tat
substrates that contain lipoboxes have also been identiﬁed,
programs that will speciﬁcally determine the presence of
lipoboxes in bacterial Tat substrate signal peptides will also
be invaluable. TatLipo provides a solid foundation for the
development of such a program.
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